Kingdon Capital Management, L.L.C. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Kingdon Capital Management, L.L.C.

$862 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $11.3 Million - $19.9 Million	-136,306 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $18.1 Million - $23.4 Million	-164,067 Reduced 54.62%	136,306 $16.2 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $6.48 Million - $9.65 Million	-65,000 Reduced 17.79%	300,373 $41.4 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $3.52 Million - $4.95 Million	-35,633 Reduced 8.89%	365,373 $50.8 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $30.2 Million - $48.2 Million	-459,255 Reduced 53.39%	401,006 $38.9 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $23.7 Million - $33.9 Million	-370,000 Reduced 30.07%	860,261 $58.8 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $5.21 Million - $7.86 Million	-80,000 Reduced 6.11%	1,230,261 $105 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $472,320 - $623,600	8,000 Added 0.61%	1,310,261 $85.2 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $4.66 Million - $11.9 Million	-160,500 Reduced 10.97%	1,302,261 $95.2 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $5.64 Million - $11.7 Million	205,041 Added 16.3%	1,462,761 $49.8 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $4.12 Million - $5.82 Million	100,946 Added 8.73%	1,257,720 $68.5 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $5.81 Million - $7.69 Million	155,364 Added 15.51%	1,156,774 $48.3 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $6.25 Million - $10.5 Million	157,144 Added 18.61%	1,001,410 $43.9 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $5.99 Million - $9.25 Million	173,528 Added 25.87%	844,266 $43.5 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $1.44 Million - $2.08 Million	48,410 Added 7.78%	670,738 $24.8 Million
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $810,962 - $1.06 Million	24,732 Added 4.14%	622,328 $23.4 Million
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $1.93 Million - $3.46 Million	81,859 Added 15.87%	597,596 $23.6 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $11.6 Million - $17.8 Million	515,737 New	515,737 $13.3 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.

Account